Oncolytics Biotech Appoints Andrew Aromando as Chief Business Officer to Enhance Business Growth Oncolytics Biotech has appointed Andrew Aromando as Chief Business Officer. With over 30 years in the industry, he will lead global development initiatives.

Oncolytics Biotech Appoints Andrew Aromando as Chief Business Officer to Enhance Business Growth #Canada #Calgary #Oncolytics_Biotech #pelareorep #Andrew_Aromando